Acknowledgements The authors wish to thank the CPFs science editor Patrick Reilly for his valuable comments on the text
Historically, scientists have referred to this compound by various names, including Growth-modulating peptide and Liver growth factor Cu-GHK, reflecting its diverse biological activity throughout the body
McLellan LI and Wolf CR
"Pharmacological Management of Obesity in Pregnancy: A Review of Current and Emerging Therapies"
Nausea was more frequent with tirzepatide vs placebo, especially with tirzepatide 15 mg (OR 5.60 [95% CI 3.12, 10.06]), associated with higher incidence of vomiting (OR 5.50 [95% CI 2.40, 12.59]) and diarrhoea (OR 3.31 [95% CI 1.40, 7.85])
What sets these injectables apart is their dual action: not only do they add volume, but they also encourage the bodys collagen production, ensuring enduring results